Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Chris Ka Pun Mok

Assistant Professor

The Chinese University of Hong Kong (CUHK)

Hong Kong

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Xinghong Dai

Associate Professor

Case Western Reserve University

UNITED STATES

View details

Louis HS Lau

Assistant Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Yun-Sang Tang

Research Assistant Professor

The University of Hong Kong

HONG KONG

View details

Liz Lirong Cao

Research Assistant Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Yuchen Wei

Research assistant professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Wan Yi Chan

Associate Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

David Hui

Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Sumana Sanyal

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chris Ka Pun Mok

Research Interests

Make your next move.

Explore related searches

Articles (20)

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.

Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial

Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain

Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.

Amino acid substitution L232F in non-structural protein 6 identified as a possible human-adaptive mutation in clade B MERS coronaviruses.

Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season – a serological study using retrospective samples collected in Hong Kong

Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines

COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition

Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants (Frontiers in Immunology, (2021), 12, (761250), 10.3389/fimmu.2021.761250)

Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings

Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study)

Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron

Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

Collaborators (8)

Xinghong Dai

Louis HS Lau

Yun-Sang Tang

Liz Lirong Cao

Yuchen Wei

Wan Yi Chan

David Hui

Sumana Sanyal

Make your next move.